Antigenicity study of the yeast-generated human parvovirus 4 (PARV4) virus-like particles-Reference-Cited by-同舟云学术

Antigenicity study of the yeast-generated human parvovirus 4 (PARV4) virus-like particles

Published:2021-01 Issue: Volume:292 Page:198236
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Lazutka Justas^ORCID,Simutis Karolis,Matulis Paulius^ORCID,Petraitytė-Burneikienė Rasa,Kučinskaitė-Kodzė Indrė,Simanavičius Martynas^ORCID,Tamošiunas Paulius Lukas^ORCID

Funder

Lietuvos Mokslo Taryba

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference47 articles.

1. Current approaches to fine mapping of antigen–antibody interactions;Abbott;Immunology,2014

2. Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of dengue 2 virus;Amexis;J. Infect. Dis.,2006

3. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity;Amrun;EBioMedicine,2020

4. Intranasal Interleukin-12 is a powerful adjuvant for protective mucosal immunity;Arulanandam;J. Infect. Dis.,1999

5. Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: a Phase 1 dose-escalation study in healthy adults;Chichester;Vaccine,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saccharomyces cerevisiae as a Model for Studying Human Neurodegenerative Disorders: Viral Capsid Protein Expression;International Journal of Molecular Sciences;2023-12-07

2. Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery;Vaccines;2023-02-18